about
A granulocytosis associated with rufinamide: A case report.A Skeletal Muscle Model of Infantile-onset Pompe Disease with Patient-specific iPS CellsMRI gadolinium enhancement precedes neuroradiological findings in acute necrotizing encephalopathy.Multiple brainstem infarctions in a boy caused by angiitis of the basilar artery.Identification of novel SNORD118 mutations in seven patients with leukoencephalopathy with brain calcifications and cysts.Is a reversible splenial lesion a sign of encephalopathy?A boy with unilateral neck myoclonus of cortical origin independently on both sides.Genotype-phenotype correlations in alternating hemiplegia of childhood.[Epileptic encephalopathy associated with human herpes virus 6 (HHV-6) encephalitis after the second cord blood transplantation in a patient with pediatric acute lymphoblastic leukemia].Long-term weekly ACTH therapy for relapsed West syndrome in tuberous sclerosis complex: A case report.[Efficacy and tolerability of topiramate, lamotrigine, and levetiracetam in children with refractory epilepsy].Familial episodic limb pain in kindreds with novel Nav1.9 mutationsHypergonadotropic hypogonadism and hypersegmented neutrophils in a patient with ataxia-telangiectasia-like disorder: potential diagnostic clues?[Contrast-enhanced MR imaging in bacterial meningitis in children--temporal profile and correlation with the prognosis]Paroxysmal gaze deviations as the sole manifestation of occipital lobe epilepsyEnzyme Replacement Therapy Provides Effective, Long-Term Treatment of Cardiomyopathy in Pompe DiseaseSomatic mosaic deletions involving SCN1A cause Dravet syndromeDe novo NSF mutations cause early infantile epileptic encephalopathyA Liver Model of Infantile-Onset Pompe Disease Using Patient-Specific Induced Pluripotent Stem CellsAcute Flaccid Myelitis With Neuroradiological Finding of Brachial Plexus Swelling[A girl with dyslexia suspected to have Irlen syndrome, completely relieved by wearing tinted lenses]
P50
Q40172544-6A061B57-232E-4641-A58B-5A9F9BC8AF44Q42677230-319D1148-25C7-4629-95DB-EC4A61E7C27EQ43521649-B496C953-E824-45DE-BE67-0956D6F2F045Q48173992-01881FC0-39AA-4F1B-92C4-C2D66D5758D4Q48263204-DC9686CB-2932-480D-8834-55480000A01BQ48529567-22B26E04-4183-457D-8259-639D11A54138Q48613977-2952B25E-041D-4955-A674-E28408F6E4C1Q50480870-5774A710-B45D-461F-836A-4A59CABC1A62Q50748268-BCB51895-4DB1-4578-BDD7-35A5B9B9134BQ52147763-AFDC7429-95C0-4F8B-AF53-5E80EF6C3374Q53660718-A70D665A-A462-46B0-A7A7-63211A3F6E9BQ60301711-8F1C22D3-A153-4413-B143-774549742ACBQ64390351-20690652-8242-402B-87BD-07D5B6B93632Q84664265-0AC929FC-0042-4D22-B4DB-859943FAB034Q87121174-0BDF255E-9B76-4137-9503-2868A8A0AFCEQ88924197-C628ECF1-5437-4A19-900C-8C41BBDCD8B1Q89887228-462874D5-0767-4CE4-A0AB-5CDAF4EF0CF7Q91055062-348BFB16-8DF4-4D6C-AC3D-9238F76AED0AQ92074872-29785AF9-ADE4-40A0-99B4-11B4C6CF223BQ94683529-17DF0964-00E9-425C-8E85-9ACD7DD1E01AQ95527223-A4761BD3-6CB9-4629-BE57-8912A87B2D26
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Takeshi Yoshida
@ast
Takeshi Yoshida
@en
Takeshi Yoshida
@es
Takeshi Yoshida
@nl
Takeshi Yoshida
@sl
type
label
Takeshi Yoshida
@ast
Takeshi Yoshida
@en
Takeshi Yoshida
@es
Takeshi Yoshida
@nl
Takeshi Yoshida
@sl
prefLabel
Takeshi Yoshida
@ast
Takeshi Yoshida
@en
Takeshi Yoshida
@es
Takeshi Yoshida
@nl
Takeshi Yoshida
@sl
P106
P108
P21
P31
P496
0000-0003-0992-064X
P569
2000-01-01T00:00:00Z